Abstract
Understanding of molecular regulatory pathways presents a novel therapeutic approach for the treatment of head and neck cancer. These specific check points are becoming the targeted therapeutic approach. In this review, we highlight certain major signaling mechanisms, which are involved in the pathophysiology of head and neck cancer. Also, we discuss the current ongoing trials based on the in vitro success of targeted therapies.
Keywords:
regulatory pathways; head and neck cancer.
MeSH terms
-
Carcinoma, Squamous Cell / genetics*
-
Carcinoma, Squamous Cell / metabolism
-
Cyclin-Dependent Kinase Inhibitor p16 / genetics
-
Cyclin-Dependent Kinase Inhibitor p16 / metabolism
-
Gene Expression Regulation, Neoplastic
-
Head and Neck Neoplasms / genetics*
-
Head and Neck Neoplasms / metabolism
-
Humans
-
Research / trends
-
Signal Transduction
-
Tumor Suppressor Protein p53 / genetics
-
Tumor Suppressor Protein p53 / metabolism
Substances
-
Cyclin-Dependent Kinase Inhibitor p16
-
Tumor Suppressor Protein p53